Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference
By SquaredTown on June 19, 2025
Key findings from the Phase III trial of Sodium Dichloroacetate (DCA) for Pyruvate Dehydrogenase Complex Deficiency (PDCD) were presented. ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical...